GLPG
GalapagosยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GLPG Profile
Galapagos Nv
A developer of small molecule medicines for the treatment of inflammatory-related diseases
Pharmaceutical
06/30/1999
05/14/2015
NASDAQ Stock Exchange
704
12-31
Depository Receipts (Ordinary Shares)
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium
--
Galapagos Nv was incorporated in Belgium on June 30, 1999. The company is a global biotechnology company with operations in Europe and the United States that develops translational medicines for more years of life and quality of life. The company focuses on highly unmet medical needs, synergizing compelling science, technology and collaborative approaches to create a deep pipeline of potentially best-in-class small molecules, CAR-T therapies, and biologics in oncology and immunology.
